ask="18.91"
ask_size="500"
average_daily_volume="287895"
bid="14.55"
bid_size="800"
book_value="3.21"
change="+0.03"
change_from_200_day_moving_average="5.70"
change_from_50_day_moving_average="1.44"
change_from_52_week_high="-5.01"
change_From_52_week_low="13.42"
change_in_percent="+0.17%"
close="18.06"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6551000"
high="18.34"
high_52_weeks="23.07"
last_trade_date="1/24/2017"
last_trade_price="18.06"
last_trade_size="1663"
last_trade_time="4:00pm"
low="17.90"
low_52_weeks="4.64"
market_capitalization="179.75M"
moving_average_200_day="12.36"
moving_average_50_day="16.62"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+46.12%"
percent_change_from_50_day_moving_average="+8.67%"
percent_change_from_52_week_high="-21.71%"
percent_change_from_52_week_low="+289.22%"
previous_close="18.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.62"
price_per_sales="3174.80"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="8.35"
stock_exchange="NGM"
symbol="ZYNE"
volume="319155"
weeks_range_52="4.64 - 23.07"
